The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation

Bone Marrow Transplant. 2021 Aug;56(8):2027-2030. doi: 10.1038/s41409-021-01311-z. Epub 2021 Apr 29.

Kosuke Toyoda^{1

2}, Jun-Ichirou Yasunaga^{3

4}, Ilseung Choi⁵, Youko Suehiro^{5

6}, Naokuni Uike⁷, Jun Okamura⁸, Masao Matsuoka^{1

2}

¹ Department of Hematology, Rheumatology and Infectious Diseases, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
² Laboratory of Virus Control, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
³ Department of Hematology, Rheumatology and Infectious Diseases, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. jyasunag@kumamoto-u.ac.jp.
⁴ Laboratory of Virus Control, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. jyasunag@kumamoto-u.ac.jp.
⁵ Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
⁶ Department of Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
⁷ Department of Hospice, St.Mary's Hospital, Fukuoka, Japan.
⁸ Institute for Clinical Research, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

No abstract available

Publication types